Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Postmarketing Adverse Experience Reporting
Published Date: 1/17/2025
Notice
Summary
The FDA is updating how drug companies report problems people have after using their medicines. This helps keep medicines safe by making sure the FDA gets clear, timely info. Drug makers need to follow new rules and send comments by February 18, 2025, but there’s no big cost change expected.
Analyzed Economic Effects
6 provisions identified: 0 benefits, 6 costs, 0 mixed.
Mandatory Electronic Adverse Event Reports
If you manufacture, pack, distribute, or sponsor drugs or biologics, all adverse experience reports and followup reports must be submitted to FDA in electronic format (via the Electronic Submissions Gateway or the Safety Reporting Portal). Waivers of the electronic requirement may be granted for good cause.
Large Estimated Increase in Paperwork Burden
FDA reports the total burden hours for this information collection have increased by 61,614,921 hours and 2,546,112 responses compared to the previous renewal; current total estimated annual reporting hours are 51,690,702 and recordkeeping hours are 24,627,827.8. FDA also estimates operating and maintenance costs of approximately $25,000 (reporting) and $22,000 (recordkeeping) annually.
Long Recordkeeping Timeframes Required
Manufacturers, applicants, packers, and distributors must keep records of adverse drug experience reports for long periods: 10 years for prescription drug applicants and manufacturers (21 CFR 314.80(j) and 310.305(g)) and 6 years for nonprescription (OTC) drug adverse event records under section 760(e).
15-Day Alerts and Periodic Reporting Deadlines
Applicants must send 15-day 'Alert' reports for serious, unexpected adverse drug experiences (Sec. 314.80(c)(1)(i)) and must submit periodic safety reports quarterly for the first 3 years after U.S. approval and annually thereafter (Sec. 314.80(c)(2) and 600.80(c)(2)).
OTC Products Included in Reporting Rules
Over-the-counter (OTC) drug products marketed without an approved application — including products under the OTC Drug Monograph Review process or marketed outside the monograph system — are required to submit adverse event reports in electronic format under section 760 and related regulations (Sec. 329.100).
5-Day Notice Rule for Combination Products
For combination products that include a drug, if an event involves death, serious injury, or an adverse event and the product sponsor receives the information, the sponsor must provide that information to the other constituent part applicant(s) no later than 5 calendar days after receipt (21 CFR 4.103).
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-12679 — International Cooperation on Harmonisation of Technical Requirements for Registration of Veterinary Medicinal Products; Effectiveness of Anthelmintics: Specific Recommendations for Bovines; Guidance for Industry; Availability
The FDA just released new guidance to help companies test worm-killing medicines for cows. This makes it easier for drug makers worldwide to prove their products work, speeding up approvals and keeping cattle healthy. Farmers, vets, and drug companies should watch for these changes starting now—no extra costs, just clearer rules!
2026-12651 — Certain Frozen Fish Fillets From Vietnam; Determination
The U.S. International Trade Commission decided to keep the extra taxes on frozen fish fillets from Vietnam because removing them could hurt American fish businesses. This means importers will still pay these duties, helping protect U.S. jobs and companies. The decision was finalized in June 2026 and affects anyone buying or selling these fish fillets in the U.S.
2026-12677 — Agency Information Collection Activity: Native American Direct Loan (NADL) Processing Requirements
The VA is renewing its info collection for the Native American Direct Loan program, which helps Native American Veterans buy or improve homes on tribal lands. This update keeps the process smooth without changes, asking for proof of tribal membership and land ownership. If you’re a Native American Veteran using this loan, get ready to share your info by July 24, 2026, with no extra costs expected.
2026-12643 — Notice of Intent To Rule on a Request To Release Surplus Property and Land Swap at the Palatka Municipal Airport, Palatka, FL
The City of Palatka wants to swap nearly 15 acres of airport land for a smaller 12-acre parcel nearby and use the released land for non-airport purposes. This swap includes a $94,000 payment to the airport fund to keep things fair. If you have thoughts, you’ve got until July 24, 2026, to speak up!
2026-12690 — Agency Information Collection Activities: Proposed Collection Renewal; Comment Request
The FDIC wants to renew its info collection forms that insured state banks and savings associations fill out about their services. No changes or new costs are planned, but they’re asking for public comments by July 24, 2026. This keeps things running smoothly without adding extra paperwork or fees.
2026-12665 — Petition for Modification of Application of Existing Mandatory Safety Standards
Fossil Rock Resources, a mining company, asked to change some safety rules to use a different method that keeps miners just as safe. This change could affect how they work but won’t reduce safety. People have until July 24, 2026, to share their thoughts, and no extra costs are expected.
Previous / Next Documents
Previous: 2025-01150 — Agency Information Collection Activities: Submission to OMB for Review and Approval; Public Comment Request; Maternal and Child Health Jurisdictional Survey Instrument for the Title V MCH Block Grant Program
HRSA is asking for public feedback on a survey tool used by states to report how they’re helping moms and kids stay healthy through the Title V MCH Block Grant program. This update aims to keep the survey clear and useful, making sure states can track their progress well. Comments are open until February 18, 2025, and this process helps keep the program effective without adding extra costs.
Next: 2025-01152 — Agency Information Collection Activities; Proposed Collection; Improving the Quality and Representativeness of the Treatment Center Program Data-Data Modifications to the Current Survey Instrument Format to Minimize Misclassification; Withdrawal of Notice
The FDA has decided to cancel a planned update to how they collect data from treatment centers, which was meant to reduce mistakes in surveys. This change affects treatment centers and anyone involved in reporting data, but now there won’t be any new forms or costs. The cancellation was announced on January 17, 2025, so no changes will happen anytime soon.